PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival

被引：0
|
作者：
Federico Verde
Cinzia Tiloca
Claudia Morelli
Alberto Doretti
Barbara Poletti
Luca Maderna
Stefano Messina
Davide Gentilini
Isabella Fogh
Antonia Ratti
Vincenzo Silani
Nicola Ticozzi
机构：
[1] Istituto Auxologico Italiano,Department of Neurology
[2] IRCCS, Stroke Unit and Laboratory of Neuroscience
[3] Istituto Auxologico Italiano,Unit of Bioinformatics and Genomic Statistics
[4] IRCCS,Department of Brain and Behavioral Sciences
[5] University of Pavia,Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute
[6] King’s College London,Department of Medical Biotechnology and Translational Medicine
[7] Università degli Studi di Milano,Department of Pathophysiology and Transplantation, “Dino Ferrari” Center
[8] Università degli Studi di Milano,“Aldo Ravelli” Center for Neurotechnology and Experimental Brain Therapeutics
[9] Università degli Studi di Milano,undefined
来源：
Neurological Sciences | 2019年 / 40卷
关键词：
ALS; Motor neurons; Paraoxonase; SNP; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1469 / 1473
页数：4
相关论文
共 50 条
  • [41] Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance
    Hussein, Yousri M.
    Gharib, Amal F.
    Etewa, Rasha L.
    ElSawy, Wael H.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 351 (1-2) : 117 - 123
  • [42] PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Man, Michael
    Duvvuru, Suman
    Walker, Joseph
    Sundseth, Scott S.
    Macias, William L.
    Antman, Elliott M.
    Braunwald, Eugene
    Sabatine, Marc S.
    CIRCULATION, 2011, 124 (21)
  • [43] The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Womens Heart and Health prospective cohort study and a meta-analysis
    Lawlor, D
    Ebrahim, S
    Day, IMN
    Gaunt, TR
    Hinks, LJ
    Briggs, PJ
    Timpson, N
    Smith, GD
    EUROPEAN HEART JOURNAL, 2004, 25 : 531 - 531
  • [44] Chiral organophosphorus insecticides are recalcitrant to the hydrolysis by alloforms PON1 Q192R of human serum
    Mederos, P.
    Almenares, D.
    Garcia, S.
    Martinez, F.
    Monroy, A.
    TOXICOLOGY LETTERS, 2016, 259 : S223 - S223
  • [45] The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis
    Debbie A Lawlor
    Ian NM Day
    Tom R Gaunt
    Lesley J Hinks
    Patricia J Briggs
    Matthew Kiessling
    Nick Timpson
    George Davey Smith
    Shah Ebrahim
    BMC Genetics, 5
  • [46] Serum PON-1 Activity but not Q192R Polymorphism is Related to the Extent of Atherosclerosis
    Bayrak, Ahmet
    Bayrak, Tulin
    Tokgozoglu, S. Lale
    Volkan-Salanci, Bilge
    Deniz, Ali
    Yavuz, Bunyamin
    Alikasifoglu, Mehmet
    Demirpence, Ediz
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (04) : 376 - 384
  • [47] PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population
    Arca, M
    Ombres, D
    Montali, A
    Campagna, F
    Mangieri, E
    Tanzilli, G
    Campa, PP
    Ricci, G
    Verna, R
    Pannitteri, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (01) : 9 - 15
  • [48] IMPACT OF Q192R OF PON1 POLYMORPHISM ON THE ENDOTHELIAL FUNCTION AND OXIDATIVE STRESS MARKERS IN THE SIMVASTATIN-TREATED CHD PATIENTS
    Domagala, T. B.
    Januszek, R.
    Kotula-Horowitz, K.
    Zagajewski, J.
    Janczura, M.
    Musial, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E226 - E227
  • [49] Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis
    Biswas, Mohitosh
    Kali, Sumaiya Khatun
    Sarker, Ashish Kumar
    Sukasem, Chonlaphat
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (09) : 807 - 817
  • [50] THE HAPLOTYPES OF L55M AND Q192R PON1 POLYMORPHISMS AND THE RISK OF PROSTATE CANCER
    Saadat, Mostafa
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (02) : 173 - 174
12345